Pfizer confirms interest in buying AstraZeneca

Pfizer (PFE) offered to purchase AstraZeneca (AZN) in January for £46.61 ($76.62) a share in cash and stock, the U.S. company said, with the proposal representing a 30% premium on AstraZeneca's shares at the time.

After "limited high-level discussions, AstraZeneca declined to pursue negotiations," Pfizer said. The latter again contacted AstraZeneca on Saturday about a deal and the latter again "declined to engage."

Pfizer is now "considering its options" and will continue to offer a premium on AstraZeneca's shares, which closed at £40.80 on Friday for a market cap of £51.47B. (PR)

From other sites
Comments (1)
  • Patent News
    , contributor
    Comments (1475) | Send Message
    how much is the company really worth??


    hostile takeover?
    28 Apr 2014, 03:03 AM Reply Like
DJIA (DIA) S&P 500 (SPY)
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs